- Posted in Business Critical | October 11, 2011 | Comments (0)
- Tags: supplier, earnings, spine, financial, market growth, sales, oem, market, earning
- By: Julie A. Vetalice
ORTHOWORLD estimates place 2Q11 market growth at 5% over 2Q10 as shown in Exhibit 1, which displays 2Q orthopaedic sales growth by product segment for select companies. Performance highlights follow.
Exhibit 1: Orthopaedic Sales1 Increases by Product Segment: 2Q11 vs. 2Q10
Notes to Exhibit 1
1 Orthopaedic products only; constant currency, pro forma growth
2 Includes biologics
3 For the quarter ended 5/31/11; trauma includes stimulators; spine includes stimulators and orthobiologics.
4 For the quarter ended 7/29/11
5 Spine
6 For the quarter ended 6/30/11
7 Extremities: extremities + fixation combined; Endoscopy: endoscopic + communications, most of which is orthopaedic; Spine: neuro + spine. Total growth excludes Patient handling.
8 ORTHOWORLD estimates
9 For the quarter ended 6/30/11
10 Excludes "Other" (Aerospace)
